You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

inactive hepatitis B virus carriers

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis B Trial in Zhengzhou (PegIFN a- 2b)

Completed
  • Chronic Hepatitis B
  • PegIFN α- 2b
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Jul 11, 2022

Chronic Hepatitis B Trial in Zhengzhou (continuous treatment, pulse therapy)

Recruiting
  • Chronic Hepatitis B
  • continuous treatment
  • pulse therapy
  • Zhengzhou, Henan, China
    Henan Provincial People's Hospital
Jul 13, 2022

Chronic Hepatitis B Trial in Beijing (PEG-IFN)

Recruiting
  • Chronic Hepatitis B
  • Beijing, Beijing, China
    Department of Hepatology Division 2, Beijing Ditan Hospital
May 9, 2022

Hepatitis B, Chronic Trial in Toronto (Tenofovir disoproxil fumarate)

Active, not recruiting
  • Hepatitis B, Chronic
  • Tenofovir disoproxil fumarate
  • Toronto, Ontario, Canada
    University Health Network - Toronto General Hospital
Nov 1, 2022

Chronic Hepatitis b Trial in Rotterdam (ISA104, Placebo)

Not yet recruiting
  • Chronic Hepatitis b
  • Rotterdam, Netherlands
    Erasmus MC
Apr 21, 2023

Gut Microbiome in People Living With HIV and HBV

Not yet recruiting
  • Human Immunodeficiency Virus
  • +2 more
    • (no location specified)
    Nov 8, 2023

    Hepatitis B Virus Reactivation:Cautionary Event After Liver

    Completed
    • Liver Transplant; Complications
    • Diagnosis of postoperative recurrence of liver cancer
    • (no location specified)
    Oct 27, 2023

    Hepatocellular Carcinoma Trial (Lenvatinib at a dose of 8 mg or 12 mg based on body weight + tislelizumab for one 21-day cycle)

    Not yet recruiting
    • Hepatocellular Carcinoma
    • Lenvatinib at a dose of 8 mg or 12 mg based on body weight + tislelizumab for one 21-day cycle
    • (no location specified)
    Jun 12, 2023

    Hepatic Steatosis and Chronic Hepatitis B Virus

    Not yet recruiting
    • Chronic Hepatitis
    • Liver biopsy
    • Sohag, Egypt
      Faculty of medicine
    Dec 28, 2022

    Cutaneous Warts Trial (Hepatitis B Virus Vaccine(HBV))

    Not yet recruiting
    • Cutaneous Warts
    • Hepatitis B Virus Vaccine(HBV)
    • (no location specified)
    Jun 13, 2023

    Hepatitis B, Chronic, Hepatitis D Trial in Chisinau, Kyiv (ATI-2173, Viread, AB-729)

    Terminated
    • Hepatitis B, Chronic
    • Hepatitis D
    • Chisinau, Republic Of Moldova, Moldova, Republic of
    • +1 more
    Nov 15, 2022

    Chronic Hepatitis b, Anti-PD-1 Antibody, Peg-IFNa Trial in Chongqing (Anti-PD-1 antibody, NAs, Peg-IFNa)

    Not yet recruiting
    • Chronic Hepatitis b
    • +2 more
    • Anti-PD-1 antibody
    • +2 more
    • Chongqing, Chongqing, China
      The 2nd affiliated Hospital of Chongqing Medical University
    Mar 14, 2023

    Chronic Hepatitis B Trial (RO7565020, Placebo, Nucleos(t)ide analogue (NUC) treatment)

    Not yet recruiting
    • Chronic Hepatitis B
    • (no location specified)
    Feb 28, 2023

    Lung Transplant, Hepatitis B Trial (Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide)

    Recruiting
    • Lung Transplant
    • Hepatitis B
    • Hepatitis B Immune Globulin and entecavir, tenofovir disoproxil, or tenofovir alafenamide
    • Philadelphia, Pennsylvania
      Hospital of University of Pennsylvania
    Oct 1, 2022

    IBD Trial (standard hepatitis B vaccine, accelerated HBV Vaccine)

    Not yet recruiting
    • Inflammatory Bowel Diseases
    • standard hepatitis B vaccine
    • accelerated HBV Vaccine
    • (no location specified)
    Jul 27, 2023

    Chronic Hepatitis b, Anti-PD-1 Antibody Trial in Chongqing (Anti-PD-1 antibody, NAs)

    Not yet recruiting
    • Chronic Hepatitis b
    • Anti-PD-1 Antibody
    • Anti-PD-1 antibody
    • NAs
    • Chongqing, Chongqing, China
      The 2nd affiliated Hospital of Chongqing Medical University
    Mar 3, 2023

    Burden of Hepatitis D Virus Infection in China Through

    Not yet recruiting
    • Hepatitis D
    • +3 more
    • HDV-Ab (IgG), HDV-RNA, RNA genotype
    • (no location specified)
    Nov 1, 2022

    Hepatitis B Virus Related Hepatocellular Carcinoma, Hepatocellular Carcinoma Recurrent Trial in New York, Hong Kong, Singapore

    Recruiting
    • Hepatitis B Virus Related Hepatocellular Carcinoma
    • Hepatocellular Carcinoma Recurrent
    • SCG101
    • New York, New York
    • +4 more
    Nov 18, 2022

    Hepatitis B Trial in France (inactive carrier)

    Completed
    • Hepatitis B
    • inactive carrier
    • Aix en Provence, France
    • +31 more
    Apr 5, 2022

    Hepatitis Flare in Previous Hepatitis B Virus Exposure Amongst

    Terminated
    • Occult Hepatitis B
    • +2 more
      • Hong Kong, Hong Kong
        The Chinese University of Hong Kong
      Jan 14, 2022

      Hepatitis B Research Network Pediatric Cohort Study (HBRN)

      Completed
      • Hepatitis B
        • San Francisco, California
        • +6 more
        May 26, 2022

        Hepatitis C Virus Infection

        Active, not recruiting
        • Hepatitis C
        • Hepatitis B
          • Bethesda, Maryland
            National Institutes of Health Clinical Center
          Dec 30, 2022

          Cell-free DNA From Junction of Hepatitis B Virus Integration in

          Active, not recruiting
          • Hepatocellular Carcinoma
            • Taipei, Taiwan
              National Taiwan University Hospital
            Apr 10, 2023

            Vaccination Reaction, Hepatitis B Virus Infection, Digestive System Disorders of Fetus and Newborn Trial in Chongqing

            Recruiting
            • Vaccination Reaction
            • +4 more
              • Chongqing, Chongqing, China
                Children's Hospital of Chongqing Medical University
              Sep 7, 2023

              Hepatitis B, Portal Hypertension Trial (Atorvastatin 10mg, Placebo)

              Not yet recruiting
              • Hepatitis B
              • Portal Hypertension
              • Atorvastatin 10mg
              • Placebo
              • (no location specified)
              Jul 29, 2022